Sancuso

Sancuso is a brand name of granisetron, approved by the FDA in the following formulation(s):

SANCUSO (granisetron - film, extended release; transdermal)

• 
  Manufacturer: PROSTRAKAN INC
  
  Approval date: September 12, 2008
  
  Strength(s): 3.1MG/24HR ^[RLD]

Has a generic version of Sancuso been approved?

No. There is currently no therapeutically equivalent version of Sancuso available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sancuso. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Transdermal granisetron
  Patent 7,608,282
  Issued: October 27, 2009
  Inventor(s): Altenschöpfer; Peter & Watkinson; Adam Charles
  Assignee(s): Strakan International Limited
  Adhesive patches for the transdermal administration of granisetron, comprise an acrylic adhesive containing non-acidic nucleophilic moieties which substantially increase flux of granisetron across the skin.
  
  Patent expiration dates:
  
  
  • October 22, 2024
    
    ✓ 
    Patent use: USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • September 12, 2011 - NEW DOSAGE FORM
  
  
  • September 12, 2011 - NEW ESTER OR SALT OF AN ACTIVE INGREDIENT
  
  

See also...

• Sancuso Consumer Information (Drugs.com)
• Sancuso Consumer Information (Wolters Kluwer)
• Sancuso transdermal Consumer Information (Cerner Multum)
• Sancuso Advanced Consumer Information (Micromedex)
• Granisetron Consumer Information (Wolters Kluwer)
• Granisetron Solution Consumer Information (Wolters Kluwer)
• Granisetron Tablets Consumer Information (Wolters Kluwer)
• Granisetron Consumer Information (Cerner Multum)
• Granisetron transdermal Consumer Information (Cerner Multum)
• Granisetron Oral, Intravenous Advanced Consumer Information (Micromedex)
• Granisetron Transdermal Advanced Consumer Information (Micromedex)
• Granisetron Hydrochloride AHFS DI Monographs (ASHP)